nach oben

Journal of Community Health

Erschienen in:

26.02.2018 | Original Paper

Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center

verfasst von: Kaan Z. Apaydin, Holly B. Fontenot, Derri L. Shtasel, Kenneth H. Mayer, Alex S. Keuroghlian

Erschienen in: Journal of Community Health | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Human papillomavirus (HPV) vaccination and anal cancer screening are valuable, yet underutilized, tools in prevention of HPV-related cancers among sexual and gender minority (SGM) populations. The aim of this study was to characterize primary care providers’ (PCPs) practices and perceptions pertaining to HPV vaccination and anal cancer screening. A survey assessing self-reported practice characteristics related to HPV vaccination and anal cancer screening, as well as perceived barriers to vaccination and anal cancer screening at the patient-, provider-, and system-level was distributed to PCPs at a Federally-Qualified Health Center that specializes in care for SGM populations in the greater Boston area. A total of 33 PCPs completed the survey. All PCPs strongly recommended HPV vaccination to their patients by emphasizing that the vaccine is extremely important or very important. Most PCPs told their patients that the HPV vaccine prevents cervical cancer (96.9%), anal cancer (96.9%), oropharyngeal cancer (72.7%), penile cancer (57.5%), and genital warts (63.6%). There is substantial variability among providers regarding recommendations for anal cancer screening and follow-up. Most PCPs perceived that patient-level factors such as poverty, mental illness, and substance use disorders were barriers to HPV vaccination and anal cancer screening. Systems-level barriers such as lack of clinical time with each patient and lack of staffing were also described as barriers to vaccination and screening. Patient-, provider- and systems-level improvements are important to increase HPV vaccination and anal cancer screening rates.

Jowett, A., & Peel, E. (2009). Chronic illness in non-heterosexual contexts: An online survey of experiences. Feminism and Psychology, 19(4), 454–474. https://doi.org/10.1177/0959353509342770.CrossRef

Gates, G. J. (2011). How many people are lesbian, gay, bisexual, and transgender ? Williams Inst. https://doi.org/10.1080/13691058.2012.673639.CrossRef

Quinn, G. P., Sanchez, J. A., Sutton, S. K., et al. (2015). Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. Cancer Sex Minor, 65(5), 384–400. https://doi.org/10.3322/caac.21288.CrossRef

Kobayashi, T., Sigel, K., & Gaisa, M. (2017). Prevalence of anal dysplasia in human immunodeficiency virus–infected transgender women. Sexually Transmitted Disease, 44(11), 714–716. https://doi.org/10.1097/OLQ.0000000000000673.CrossRef

Silverberg, M. J., Lau, B., Justice, A. C., et al. (2012). Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clinical Infectious Disease, 54(7), 1026–1034. https://doi.org/10.1093/cid/cir1012.CrossRef

McNamara, M., Batur, P., Walsh, J. M. E., & Johnson, K. M. (2016). HPV update: vaccination, Screening, and associated disease. Journal of General Internal Medicine, 31(11), 1360–1366. https://doi.org/10.1007/s11606-016-3725-z.CrossRefPubMedPubMedCentral

Meites, E., Kempe, A., & Markowitz, L. E. (2016). Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the advisory committee on immunization practices. MMWR Morbidity and Mortality Weekly Report, 65(49), 1405–1408. https://doi.org/10.15585/mmwr.mm6549a5.CrossRefPubMed

Iversen, O.-E., Miranda, M. J., Ulied, A., et al. (2016). Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. JAMA, 316(22), 2411. https://doi.org/10.1001/jama.2016.17615.CrossRefPubMed

Markowitz LE, Dunne EF, Saraiya M, et al. Human Papillomavirus vaccination recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendation Reports. 2014;63(1):1–30. http://www.scopus.com/inward/record.url?eid=2-s2.0-84907813308&partnerID=tZOtx3y1.

10.

Machalek, D. A., Poynten, M., Jin, F., et al. (2012). Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis. Lancet Oncology, 13(5), 487–500. https://doi.org/10.1016/S1470-2045(12)70080-3.CrossRefPubMed

11.

Daling, J. R., Madeleine, M. M., Johnson, L. G., et al. (2004). Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer, 101(2), 270–280. https://doi.org/10.1002/cncr.20365.CrossRefPubMed

12.

Meites, E., Markowitz, L. E., Paz-Bailey, G., et al. (2014). HPV vaccine coverage among men who have sex with men—National HIV Behavioral Surveillance System, United States, 2011. Vaccine, 32(48), 6356–6359. https://doi.org/10.1016/j.vaccine.2014.09.033.CrossRefPubMedPubMedCentral

13.

Reiter, P. L., McRee, A.-L., Katz, M. L., & Paskett, E. D. (2015). Human papillomavirus vaccination among young adult gay and bisexual men in the United States. American Journal of Public Health, 105(1), 96–102. https://doi.org/10.2105/AJPH.2014.302095.CrossRefPubMedPubMedCentral

14.

Cummings, T., Kasting, M. L., Rosenberger, J. G., Rosenthal, S. L., Zimet, G. D., & Stupiansky, N. W. (2015). Catching up or missing out? Human papillomavirus vaccine acceptability among 18- to 26-year-old men who have sex with men in a US national sample. Sexually Transmitted Disease, 42(11), 601–606. https://doi.org/10.1097/OLQ.0000000000000358.CrossRef

15.

Gorbach, P. M., Cook, R., Gratzer, B., et al. (2017). Human papillomavirus vaccination among young men who have sex with men and transgender women in 2 US cities. Sexually Transmitted Disease, 44(7), 436–441. https://doi.org/10.1097/OLQ.0000000000000626.CrossRef

16.

Medical Advisory Secretariat. (2007). Anal dysplasia screening: An evidence-based analysis. Vol 7, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3377578&tool=pmcentrez&rendertype=abstract.

17.

New York State Department of Health AIDS Institute (2007). Anal dysplasia and cancer. Retreived June 23, 2017 from http://www.hivguidelines.org/adult-hiv/preventive-care-screening/anal-dysplasia-cancer/.

18.

Palefsky, J. (2001). Screening for anal and cervical dysplasia in HIV-infected patients. PRN Notebook, 6(3), 24–31.

19.

Goldie, S. J. (1999). The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA, 281(19), 1822. https://doi.org/10.1001/jama.281.19.1822.CrossRefPubMed

20.

D’Souza, G., Rajan, S. D., Bhatia, R., et al. (2013). Uptake and predictors of anal cancer screening in men who have sex with men. American Journal of Public Health, 103(9), 88–95. https://doi.org/10.2105/AJPH.2013.301237.CrossRef

21.

D’Souza, G., Cook, R. L., Ostrow, D., Johnson-Hill, L. M., Wiley, D., & Silvestre, T. (2008). Anal cancer screening behaviors and intentions in men who have sex with men. Journal of Genernal Internal Medicine, 23(9), 1452–1457. https://doi.org/10.1007/s11606-008-0698-6.CrossRef

22.

Mayer, K., Appelbaum, J., Rogers, T., Lo, W., Bradford, J., & Boswell, S. (2001). The evolution of the fenway community health model. American Journal of Public Health, 91(6), 892–894.CrossRefPubMedPubMedCentral

23.

Fenway Health Annual Report. (2016) Boston, MA.

24.

Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)—A metadata driven methodology and workflow process for providing translational research informatict support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010.Research.CrossRefPubMed

25.

Gilkey, M. B., Malo, T. L., Shah, P. D., Hall, M. E., & Brewer, N. T. (2015). Quality of physician communication about human papillomavirus vaccine: Findings from a National Survey. Cancer Epidemiology and Prevention Biomarkers, 24(11), 1673–1679. https://doi.org/10.1158/1055-9965.EPI-15-0326.CrossRef

26.

Gerend, M. A., Madkins, K., Phillips, G., & Mustanski, B. (2016). Predictors of human papillomavirus vaccination among young men who have sex with men. Sexually Transmitted Disease, 43(3), 185–191. https://doi.org/10.1097/OLQ.0000000000000408.CrossRef

27.

Hendry, M., Pasterfield, D., Gollins, S., et al. (2017). Talking about human papillomavirus and cancer: Development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary data. British Medical Journal Open, 7(6), e015413. https://doi.org/10.1136/bmjopen-2016-015413.CrossRef

28.

Brewer, N. T., Ng, T. W., McRee, A. L., & Reiter, P. L. (2010). Men’s beliefs about HPV-related disease. Journal of Behavioral Medicine, 33(4), 274–281. https://doi.org/10.1007/s10865-010-9251-2.CrossRefPubMedPubMedCentral

29.

Ylitalo, K. R., Lee, H., & Mehta, N. K. (2013). Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US national immunization survey. American Journal of Public Health, 103(1), 164–169. https://doi.org/10.2105/AJPH.2011.300600.CrossRefPubMedPubMedCentral

30.

Gilkey, M. B., Calo, W. A., Moss, J. L., Shah, P. D., Marciniak, M. W., & Brewer, N. T. (2016). Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine, 34(9), 1187–1192. https://doi.org/10.1016/j.vaccine.2016.01.023.CrossRefPubMedPubMedCentral

31.

Krantz, L., Ollberding, N. J., Beck, A. F., & Carol Burkhardt, M. (2017). Increasing HPV vaccination coverage through provider-based interventions. Clinical Pediatrics (Phila). https://doi.org/10.1177/0009922817722014.CrossRef

32.

Mcree, A., Katz, M. L., Paskett, E. D., & Reiter, P. L. (2014). HPV vaccination among lesbian and bisexual women: Findings from a national survey of young adults. Vaccine, 32(37), 4736–4742. https://doi.org/10.1016/j.vaccine.2014.07.001.CrossRefPubMedPubMedCentral

33.

Keuroghlian, A., Ard, K., & Makadon, H. Advancing health equity for lesbian, gay, bisexual and transgender (LGBT) people through sexual health education and LGBT-affirming health care environments. Sex Health. 2017:119–122. https://doi.org/10.1071/SH16145.

34.

Reisner, S. L., Bradford, J., Hopwood, R., et al. (2015). Comprehensive transgender healthcare: The gender affirming clinical and public health model of fenway health. Journal of Urban Health, 92(3), 584–592. https://doi.org/10.1007/s11524-015-9947-2.CrossRefPubMedPubMedCentral

35.

HPV vaccine, adolescents, 2008–2012. Retrieved January 3, 2018 from https://www.healthypeople.gov/2020/topics-objectives/national-snapshot/hpv-vaccine-adolescents-2008-2012.

36.

Clark, C. R., Baril, N., Hall, A., et al. (2011). Case management intervention in cervical cancer prevention: The Boston REACH Coalition Women’s Health Demonstration Project. Progress in Community Health Partnership, Fall(5(3), 235–247.CrossRef

37.

Fontenot, H. B., Lee-St. John, T., Vetters, R., Funk, D., Grasso, C., & Mayer, K. H. (2016). The association of health seeking behaviors with human papillomavirus vaccination status among high-risk urban youth. Sexually Transmitted Disease, 43(12), 771–777. https://doi.org/10.1097/OLQ.0000000000000521.CrossRef

38.

Sussman, A. L., Helitzer, D., Bennett, A., Solares, A., Lanoue, M., & Getrich, C. M. (2015). Catching up with the HPV vaccine: Challenges and opportunities in primary care. Annals of Family Medicine, 13(4), 354–360. https://doi.org/10.1370/afm.1821.CrossRefPubMedPubMedCentral

39.

Farmar, A.-L. M., Love-Osborne, K., Chichester, K., Breslin, K., Bronkan, K., & Hambidge, S. J. (2016). Achieving high adolescent HPV vaccination coverage. Pediatrics, 138(5), e20152653. https://doi.org/10.1542/peds.2015-2653.CrossRefPubMed

40.

Fontenot, H. B., Fantasia, H. C., Vetters, R., & Zimet, G. D. (2016). Increasing HPV vaccination and eliminating barriers: Recommendations from young men who have sex with men. Vaccine, 34(50), 6209–6216. https://doi.org/10.1016/j.vaccine.2016.10.075.CrossRefPubMed

41.

Reed, A. C., Reiter, P. L., Smith, J. S., Palefsky, J. M., & Brewer, N. T. (2010). Gay and bisexual men’s willingness to receive anal papanicolaou testing. American Journal of Public Health, 100(6), 1123–1129. https://doi.org/10.2105/AJPH.2009.176446.CrossRefPubMedPubMedCentral

42.

Pitts, M. K., Fox, C., Willis, J., & Anderson, J. (2007). What do gay men know about human papillomavirus? Australian gay men’s knowledge and experience of anal cancer screening and human papillomavirus. Sexually Transmitted Disease, 34(3), 170–173. https://doi.org/10.1097/01.olq.0000230436.83029.ce.CrossRef

43.

Siekas, L. L., & Aboulafia, D. M. (2009). Establishing an anal dysplasia clinic for HIV-infected men: initial experience. AIDS Read, 19(5), 178–186.PubMed

44.

Schochet, E. (2011). You want to stick that where?: A guide to the anal pap smear before, during, and after. Journal of the Association of Nurses in AIDS Care, 22(6), 502–504.CrossRefPubMed

45.

Walker, C. M., Likes, W., Bernard, M., Kedia, S., & Tolley, E. (2016). Risk of anal cancer in people living with HIV: Addressing anal health in the HIV primary care setting. Journal of the Association of Nurses in AIDS Care, 27(5), 563–573. https://doi.org/10.1016/j.jana.2016.02.012.CrossRefPubMed

46.

Taylor, S., Bunge, E., Bakker, M., & Castellsagué, X. (2016). The incidence, clearance and persistence of non-cervical human papillomavirus infections: A systematic review of the literature. BMC Infectious Diseases, 16(1), 293. https://doi.org/10.1186/s12879-016-1633-9.CrossRefPubMedPubMedCentral

47.

Lee, E. Q., & Goldstone, S. E. (2011). Predictors of anal dysplasia in men who have sex with men with benign cytology. Diseases of the Colon Rectum, 54(3), 347–351. https://doi.org/10.1007/DCR.0b013e3181f46dc4.CrossRefPubMed

48.

Scott, H., Khoury, J., Moore, B. A., & Weissman, S. (2008). Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sexually Transmitted Disease, 35(2), 197–202. https://doi.org/10.1097/OLQ.0b013e31815aba8c.CrossRef

49.

Gee, R. (2006). Primary care health issues among men who have sex with men. Journal of American Academy Nurse Practice, 18(4), 144–153. https://doi.org/10.1111/j.1745-7599.2006.00117.x.CrossRef

Titel: Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center
verfasst von: Kaan Z. Apaydin
Holly B. Fontenot
Derri L. Shtasel
Kenneth H. Mayer
Alex S. Keuroghlian
Publikationsdatum: 26.02.2018
Verlag: Springer US
Erschienen in: Journal of Community Health / Ausgabe 4/2018
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-018-0486-0

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Cultural Factors Influencing Osteoarthritis Care in Asian Communities: A Review of the Evidence

Community Health Advisors’ Participation in a Dissemination and Implementation Study of an Evidence-Based Physical Activity and Healthy Eating Program in a Faith-Based Setting

Heads Up, Phones Down: A Pedestrian Safety Intervention on Distracted Crosswalk Behavior

Scope of Knowledge About Zika Among Women in US–Mexico Border Communities

An Electronic Medical Record Alert Intervention to Improve HPV Vaccination Among Eligible Male College Students at a University Student Health Center

Discrimination and Health Among Taxi Drivers in New York and Toronto